0001831900-22-000001.txt : 20221201 0001831900-22-000001.hdr.sgml : 20221201 20221130213134 ACCESSION NUMBER: 0001831900-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221130 EFFECTIVENESS DATE: 20221201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Equilibre BioPharmaceuticals Corp. CENTRAL INDEX KEY: 0001831900 IRS NUMBER: 853484646 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466233 FILM NUMBER: 221437136 BUSINESS ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-308-6000 MAIL ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001831900 Equilibre BioPharmaceuticals Corp. 430 E 29th St. NEW YORK NY NEW YORK 10016 332-400-0300 DELAWARE Equilibre Newco A Corp. None Corporation true 2020 Steven N. Gordon 430 E 29th St. New York NY NEW YORK 10016 Executive Officer Director Philip A. Barach 430 E 29th St. New York NY NEW YORK 10016 Executive Officer Director David Friedman 430 E 29th St. New York NY NEW YORK 10016 Director Francois Maisonrouge 430 E 29th St. New York NY NEW YORK 10016 Director Christina Ramirez 430 E 29th St. New York NY NEW YORK 10016 Director Peter M. Simon 430 E 29th St. New York NY NEW YORK 10016 Director Christopher Thorn 430 E 29th St. New York NY NEW YORK 10016 Director Pharmaceuticals Decline to Disclose 06b false 2022-11-16 false true false 0 6000002 6000002 0 false 13 0 0 0 false Equilibre BioPharmaceuticals Corp. /s/ Steven N. Gordon Steven N. Gordon Chief Operating Officer 2022-11-30